| Typicality: | 0.196 |
| Saliency: | 0.079 |
| in three clinical guidelines | 6 | temporal |
| benzodiazepine → show → significant improvement of symptoms | 4 |
| negative | neutral | positive |
| 0.006 | 0.158 | 0.836 |
| Raw frequency | 4 |
| Normalized frequency | 0.079 |
| Modifier score | 0.500 |
| Perplexity | 37.024 |